CADLCandel Therapeutics, Inc.

Nasdaq candeltx.com


$ 6.59 $ -0.16 (-2.37 %)    

Wednesday, 11-Sep-2024 15:59:48 EDT
QQQ $ 468.75 $ 0.00 (0 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 6.59
$ 6.57 x 200
-- x --
-- - --
$ 0.66 - $ 14.30
191,036
na
211.44M
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-29-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 09-08-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 candel-therapeutics-q2-eps-074-down-from-033-yoy

Candel Therapeutics (NASDAQ:CADL) reported quarterly losses of $(0.74) per share. This is a 124.24 percent decrease over losses...

 genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

 genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

 why-biorestorative-therapies-stock-is-moving-higher-thursday

BioRestorative Therapies announced before the market opened on Thursday that it engaged in substantive licensing discussions wi...

 candel-therapeutics-to-join-russell-3000-index-effective-at-the-open-of-us-equity-markets-on-monday-july-1-2024

Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical stage biopharmaceutical company focused on developi...

Core News & Articles
Market-Moving News for May 30th
05/30/2024 12:41:17

ONMD: 66% | OneMedNet shares are trading higher after the company announced that it has entered into a non-exclusive three-year...

 candel-therapeutics-to-present-data-from-its-phase-2-clinical-trial-of-can-2409-at-asco

As of the data cut-off date, CAN-2409 treatment in NSCLC continued to exhibit a favorable safety and tolerability profile

 candel-therapeutics-q1-eps-028-up-from-030-yoy

Candel Therapeutics (NASDAQ:CADL) reported quarterly losses of $(0.28) per share. This is a 6.67 percent increase over losses o...

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION